Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Nuclear Medicine
Published in: Annals of Nuclear Medicine 9/2022

14-07-2022 | Positron Emission Tomography | Review Article

Advances in positron emission tomography tracers related to vascular calcification

Authors: Wenjun Yang, Zhiqi Zhong, Guoquan Feng, Zhongqun Wang

Published in: Annals of Nuclear Medicine | Issue 9/2022

Login to get access

Abstract

Microcalcification, a type of vascular calcification, increases the instability of plaque and easily leads to acute clinical events. Positron emission tomography (PET) is a new examination technology with significant advantages in identifying vascular calcification, especially microcalcification. The use of the 18F-NaF is undoubtedly the benchmark, and other PET tracers related to vascular calcification are also currently in development. Despite all this, a large number of studies are still needed to further clarify the specific mechanisms and characteristics. This review aimed at providing a summary of the application and progress of different PET tracers and also the future development direction.
Literature
1.
Bellinge JW, Francis RJ, Majeed K, Watts GF, Schultz CJ. In search of the vulnerable patient or the vulnerable plaque: (18)F-sodium fluoride positron emission tomography for cardiovascular risk stratification. J Nucl Cardiol. 2018;25(5):1774–83.PubMedCrossRef
2.
Blomberg BA, Thomassen A, Takx RA, Vilstrup MH, Hess S, Nielsen AL, et al. Delayed sodium 18F-fluoride PET/CT imaging does not improve quantification of vascular calcification metabolism: results from the CAMONA study. J Nucl Cardiol. 2014;21(2):293–304.PubMedCrossRef
3.
Ahmed M, McPherson R, Abruzzo A, Thomas SE, Gorantla VR. Carotid artery calcification: what we know so far. Cureus. 2021;13(10): e18938.PubMedPubMedCentral
4.
Saba L, Nardi V, Cau R, Gupta A, Kamel H, Suri JS, et al. Carotid artery plaque calcifications: lessons from histopathology to diagnostic imaging. Stroke. 2022;53(1):290–7.PubMedCrossRef
5.
Tzolos E, Dweck MR. (18)F-sodium fluoride ((18)F-NaF) for imaging microcalcification activity in the cardiovascular system. Arterioscler Thromb Vasc Biol. 2020;40(7):1620–6.PubMedPubMedCentralCrossRef
6.
Cocker MS, Spence JD, Hammond R, Wells G, deKemp RA, Lum C, et al. [(18)F]-NaF PET/CT identifies active calcification in carotid plaque. JACC Cardiovasc Imaging. 2017;10(4):486–8.PubMedCrossRef
7.
8.
Vancheri F, Longo G, Vancheri S, Danial JSH, Henein MY. Coronary artery microcalcification: imaging and clinical implications. Diagnostics (Basel). 2019;9(4):125. CrossRef
9.
Nogales P, Velasco C, Mota-Cobián A, González-Cintado L, Mota RA, España S, et al. Analysis of (18)F-sodium fluoride positron emission tomography signal sources in atherosclerotic Minipigs shows specific binding of (18)F-sodium fluoride to plaque calcifications. Arterioscler Thromb Vasc Biol. 2021;41(10):e480–90.PubMedCrossRef
10.
Wang Z, Li L, Yan J, Sun Z, Shao C, Jing L, et al. Application of a targeted molecular probe in vascular calcification detection products: China, CN201811536247.X[P]. 2019;11–5.
11.
Evans NR, Tarkin JM, Le EP, Sriranjan RS, Corovic A, Warburton EA, et al. Integrated cardiovascular assessment of atherosclerosis using PET/MRI. Br J Radiol. 2020;93(1113):20190921.PubMedPubMedCentralCrossRef
12.
Li X, Heber D, Cal-Gonzalez J, Karanikas G, Mayerhoefer ME, Rasul S, et al. Association between osteogenesis and inflammation during the progression of calcified plaque evaluated by (18)F-fluoride and (18)F-FDG. J Nucl Med. 2017;58(6):968–74.PubMedCrossRef
13.
Pellico J, Fernández-Barahona I, Ruiz-Cabello J, Gutiérrez L, Muñoz-Hernando M, Sánchez-Guisado MJ, et al. HAP-multitag, a PET and positive MRI contrast nanotracer for the longitudinal characterization of vascular calcifications in atherosclerosis. ACS Appl Mater Interfaces. 2021;13(38):45279–90.PubMedPubMedCentralCrossRef
14.
Doris MK, Meah MN, Moss AJ, Andrews JPM, Bing R, Gillen R, et al. Coronary (18)F-fluoride uptake and progression of coronary artery calcification. Circ Cardiovasc Imaging. 2020;13(12): e011438.PubMedPubMedCentralCrossRef
15.
Hu Y, Hu P, Hu B, Chen W, Cheng D, Shi H. Dynamic monitoring of active calcification in atherosclerosis by (18)F-NaF PET imaging. Int J Cardiovasc Imaging. 2021;37(2):731–9.PubMedCrossRef
16.
Abdelbaky A, Corsini E, Figueroa AL, Fontanez S, Subramanian S, Ferencik M, et al. Focal arterial inflammation precedes subsequent calcification in the same location: a longitudinal FDG-PET/CT study. Circ Cardiovasc Imaging. 2013;6(5):747–54.PubMedCrossRef
17.
Al-Enezi MS, Abdo RA, Mokeddem MY, Slimani FAA, Khalil A, Fulop T, et al. Assessment of artery calcification in atherosclerosis with dynamic 18F-FDG-PET/CT imaging in elderly subjects. Int J Cardiovasc Imaging. 2019;35(5):947–54.PubMedCrossRef
18.
Nakahara T, Dweck MR, Narula N, Pisapia D, Narula J, Strauss HW. Coronary artery calcification: from mechanism to molecular imaging. JACC Cardiovasc Imaging. 2017;10(5):582–93.PubMedCrossRef
19.
Nakahara T, Narula J, Fox JJ, Jinzaki M, Strauss HW. Temporal relationship between (18)F-sodium fluoride uptake in the abdominal aorta and evolution of CT-verified vascular calcification. J Nucl Cardiol. 2021;28(5):1936–45.PubMedCrossRef
20.
Blomberg BA, de Jong PA, Thomassen A, Lam MGE, Vach W, Olsen MH, et al. Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study. Eur J Nucl Med Mol Imaging. 2017;44(2):249–58.PubMedCrossRef
21.
Høilund-Carlsen PF, Moghbel MC, Gerke O, Alavi A. Evolving role of PET in detecting and characterizing atherosclerosis. PET Clin. 2019;14(2):197–209.PubMedCrossRef
22.
Cho SG, Park KS, Kim J, Kang SR, Kwon SY, Seon HJ, et al. Prediction of coronary artery calcium progression by FDG uptake of large arteries in asymptomatic individuals. Eur J Nucl Med Mol Imaging. 2017;44(1):129–40.PubMedCrossRef
23.
Dunphy MP, Freiman A, Larson SM, Strauss HW. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med. 2005;46(8):1278–84.PubMed
24.
Lensen KDF, Voskuyl AE, Comans EFI, van der Laken CJ, Boellaard R, Smulders YM. Should vascular wall (18)F-FDG uptake be adjusted for the extent of atherosclerotic burden? Int J Cardiovasc Imaging. 2020;36(3):545–51.PubMedCrossRef
25.
Guaraldi G, Milic J, Prandini N, Ligabue G, Esposito F, Ciusa G, et al. (18)Fluoride-based molecular imaging of coronary atherosclerosis in HIV infected patients. Atherosclerosis. 2020;297:127–35.PubMedCrossRef
26.
Mayer M, Borja AJ, Hancin EC, Auslander T, Revheim ME, Moghbel MC, et al. Imaging atherosclerosis by PET, with emphasis on the role of FDG and NaF as potential biomarkers for this disorder. Front Physiol. 2020;11: 511391.PubMedPubMedCentralCrossRef
27.
Weiberg D, Thackeray JT, Daum G, Sohns JM, Kropf S, Wester HJ, et al. Clinical molecular imaging of chemokine receptor CXCR4 expression in atherosclerotic plaque using (68)Ga-pentixafor PET: correlation with cardiovascular risk factors and calcified plaque burden. J Nucl Med. 2018;59(2):266–72.PubMedCrossRef
28.
Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, et al. Coronary artery PET/MR imaging: feasibility, limitations, and solutions. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1103–12.PubMedPubMedCentralCrossRef
29.
Raynor WY, Park PSU, Borja AJ, Sun Y, Werner TJ, Ng SJ, et al. PET-based imaging with (18)F-FDG and (18)F-NaF to assess inflammation and microcalcification in atherosclerosis and other vascular and thrombotic disorders. Diagnostics (Basel). 2021;11(12):2234.PubMedCentralCrossRef
30.
Saboury B, Edenbrandt L, Piri R, Gerke O, Werner T, Arbab-Zadeh A, et al. Alavi-Carlsen calcification score (ACCS): a simple measure of global cardiac atherosclerosis burden. Diagnostics (Basel). 2021;11(8):1421.CrossRef
31.
Florea A, Morgenroth A, Bucerius J, Schurgers LJ, Mottaghy FM. Locking and loading the bullet against micro-calcification. Eur J Prev Cardiol. 2020;2047487320911138. CrossRefPubMed
32.
Doris MK, Newby DE. Identification of early vascular calcification with (18)F-sodium fluoride: potential clinical application. Expert Rev Cardiovasc Ther. 2016;14(6):691–701.PubMedCrossRef
33.
Kwiecinski J, Slomka PJ, Dweck MR, Newby DE, Berman DS. Vulnerable plaque imaging using (18)F-sodium fluoride positron emission tomography. Br J Radiol. 2020;93(1113):20190797.PubMedCrossRef
34.
Blomberg BA, Thomassen A, de Jong PA, Simonsen JA, Lam MG, Nielsen AL, et al. Impact of personal characteristics and technical factors on quantification of sodium 18F-fluoride uptake in human arteries: prospective evaluation of healthy subjects. J Nucl Med. 2015;56(10):1534–40.PubMedCrossRef
35.
Kwiecinski J, Berman DS, Lee SE, Dey D, Cadet S, Lassen ML, et al. Three-hour delayed imaging improves assessment of coronary (18)F-sodium fluoride PET. J Nucl Med. 2019;60(4):530–5.PubMedPubMedCentralCrossRef
36.
den Harder AM, Wolterink JM, Bartstra JW, Spiering W, Zwakenberg SR, Beulens JW, et al. Vascular uptake on (18)F-sodium fluoride positron emission tomography: precursor of vascular calcification? J Nucl Cardiol. 2021;28(5):2244–54.CrossRef
37.
38.
Ishiwata Y, Kaneta T, Nawata S, Hino-Shishikura A, Yoshida K, Inoue T. Quantification of temporal changes in calcium score in active atherosclerotic plaque in major vessels by (18)F-sodium fluoride PET/CT. Eur J Nucl Med Mol Imaging. 2017;44(9):1529–37.PubMedCrossRef
39.
Bellinge JW, Francis RJ, Lee SC, Phillips M, Rajwani A, Lewis JR, et al. (18)F-sodium fluoride positron emission tomography activity predicts the development of new coronary artery calcifications. Arterioscler Thromb Vasc Biol. 2021;41(1):534–41.PubMed
40.
Høilund-Carlsen PF, Piri R, Constantinescu C, Iversen KK, Werner TJ, Sturek M, et al. Atherosclerosis imaging with (18)F-sodium fluoride PET. Diagnostics (Basel). 2020;10(10):852.CrossRef
41.
Fiz F, Morbelli S, Piccardo A, Bauckneht M, Ferrarazzo G, Pestarino E, et al. 18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: inverse correlation between calcification density and mineral metabolic activity. J Nucl Med. 2015;56(7):1019–23.PubMedCrossRef
42.
Chowdhury MM, Tarkin JM, Albaghdadi MS, Evans NR, Le EPV, Berrett TB, et al. Vascular positron emission tomography and restenosis in symptomatic peripheral arterial disease: a prospective clinical study. JACC Cardiovasc Imaging. 2020;13(4):1008–17.PubMedPubMedCentralCrossRef
43.
Forsythe RO, Dweck MR, McBride OMB, Vesey AT, Semple SI, Shah ASV, et al. (18)F-sodium fluoride uptake in abdominal aortic aneurysms: the SoFIA(3) study. J Am Coll Cardiol. 2018;71(5):513–23.PubMedPubMedCentralCrossRef
44.
Nakahara T, Narula J, Tijssen JGP, Agarwal S, Chowdhury MM, Coughlin PA, et al. (18)F-fluoride positron emission tomographic imaging of penile arteries and erectile dysfunction. J Am Coll Cardiol. 2019;73(12):1386–94.PubMedCrossRef
45.
Gutierrez-Cardo A, Lillo E, Murcia-Casas B, Carrillo-Linares JL, García-Argüello F, Sánchez-Sánchez P, et al. Skin and arterial wall deposits of 18F-NaF and severity of disease in patients with pseudoxanthoma elasticum. J Clin Med. 2020;9(5):1393.PubMedCentralCrossRef
46.
Omarjee L, Mention PJ, Janin A, Kauffenstein G, Pabic EL, Meilhac O, et al. Assessment of inflammation and calcification in pseudoxanthoma elasticum arteries and skin with 18F-FluroDeoxyGlucose and 18F-sodium fluoride positron emission tomography/computed tomography imaging: The GOCAPXE Trial. J Clin Med. 2020;9(11):3448.PubMedCentralCrossRef
47.
Bhattaru A, Rojulpote C, Gonuguntla K, Patil S, Karambelkar P, Vuthaluru K, et al. An understanding of the atherosclerotic molecular calcific heterogeneity between coronary, upper limb, abdominal, and lower extremity arteries as assessed by NaF PET/CT. Am J Nucl Med Mol Imaging. 2021;11(1):40–5.PubMedPubMedCentral
48.
Cox AJ, Hsu FC, Agarwal S, Freedman BI, Herrington DM, Carr JJ, et al. Prediction of mortality using a multi-bed vascular calcification score in the Diabetes Heart Study. Cardiovasc Diabetol. 2014;13:160.PubMedPubMedCentralCrossRef
49.
Sorci O, Batzdorf AS, Mayer M, Rhodes S, Peng M, Jankelovits AR, et al. (18)F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification. Eur J Nucl Med Mol Imaging. 2020;47(7):1678–87.PubMedCrossRef
50.
Kwiecinski J, Dey D, Cadet S, Lee SE, Tamarappoo B, Otaki Y, et al. Predictors of 18F-sodium fluoride uptake in patients with stable coronary artery disease and adverse plaque features on computed tomography angiography. Eur Heart J Cardiovasc Imaging. 2020;21(1):58–66.PubMedCrossRef
51.
Keeling GP, Sherin B, Kim J, San Juan B, Grus T, Eykyn TR, et al. [(68)Ga]Ga-THP-Pam: a bisphosphonate PET tracer with facile radiolabeling and broad calcium mineral affinity. Bioconjug Chem. 2021;32(7):1276–89.PubMedCrossRef
52.
Kircher M, Tran-Gia J, Kemmer L, Zhang X, Schirbel A, Werner RA, et al. Imaging inflammation in atherosclerosis with CXCR4-directed (68)Ga-pentixafor PET/CT: correlation with (18)F-FDG PET/CT. J Nucl Med. 2020;61(5):751–6.PubMedCrossRef
53.
Bartlett B, Ludewick HP, Lee S, Verma S, Francis RJ, Dwivedi G. Imaging inflammation in patients and animals: focus on PET imaging the vulnerable plaque. Cells. 2021;10(10):2573.PubMedPubMedCentralCrossRef
54.
Duarte PS, Marin JFG, De Carvalho JWA, Sapienza MT, Buchpiguel CA. Brain metastasis of medullary thyroid carcinoma without macroscopic calcification detected first on 68Ga-dotatate and then on 18F-fluoride PET/CT. Clin Nucl Med. 2018;43(8):623–4.PubMedCrossRef
55.
Itani M, Haq A, Amin M, Mhlanga J, Lenihan D, Iravani A, et al. Myocardial uptake of (68)Ga-DOTATATE: correlation with cardiac disease and risk factors. Acta Radiol. 2021;2841851211054193. CrossRefPubMed
56.
Pedersen SF, Sandholt BV, Keller SH, Hansen AE, Clemmensen AE, Sillesen H, et al. 64Cu-DOTATATE PET/MRI for detection of activated macrophages in carotid atherosclerotic plaques: studies in patients undergoing endarterectomy. Arterioscler Thromb Vasc Biol. 2015;35(7):1696–703.PubMedPubMedCentralCrossRef
57.
Xu SN, Zhou X, Zhu CJ, Qin W, Zhu J, Zhang KL, et al. Nϵ-Carboxymethyl-lysine deteriorates vascular calcification in diabetic atherosclerosis induced by vascular smooth muscle cell-derived foam cells. Front Pharmacol. 2020;11:626.PubMedPubMedCentralCrossRef
58.
Xu H, Wang Z, Wang Y, Hu S, Liu N. Biodistribution and elimination study of fluorine-18 labeled Nε-carboxymethyl-lysine following intragastric and intravenous administration. PLoS ONE. 2013;8(3): e57897.PubMedPubMedCentralCrossRef
59.
van Eupen MG, Schram MT, Colhoun HM, Scheijen JL, Stehouwer CD, Schalkwijk CG. Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification. Cardiovasc Diabetol. 2013;12:149.PubMedPubMedCentralCrossRef
60.
Hecht E, Freise C, Websky KV, Nasser H, Kretzschmar N, Stawowy P, et al. The matrix metalloproteinases 2 and 9 initiate uraemic vascular calcifications. Nephrol Dial Transplant. 2016;31(5):789–97.PubMedCrossRef
61.
Schäfers M, Riemann B, Kopka K, Breyholz HJ, Wagner S, Schäfers KP, et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation. 2004;109(21):2554–9.PubMedCrossRef
62.
Ohshima S, Petrov A, Fujimoto S, Zhou J, Azure M, Edwards DS, et al. Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein E or low-density-lipoprotein receptor. J Nucl Med. 2009;50(4):612–7.PubMedCrossRef
63.
Fujimoto S, Hartung D, Ohshima S, Edwards DS, Zhou J, Yalamanchili P, et al. Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. J Am Coll Cardiol. 2008;52(23):1847–57.PubMedCrossRef
64.
Kato K, Schober O, Ikeda M, Schäfers M, Ishigaki T, Kies P, et al. Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging. 2009;36(10):1622–8.PubMedCrossRef
65.
Hara T, Kondo T, Hara T, Kosaka N. Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg. 2003;99(3):474–9.PubMedCrossRef
66.
Bucerius J, Schmaljohann J, Böhm I, Palmedo H, Guhlke S, Tiemann K, et al. Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans—first results. Eur J Nucl Med Mol Imaging. 2008;35(4):815–20.PubMedCrossRef
67.
Love WD, Romney RB, Burch GE. A comparison of the distribution of potassium and exchangeable rubidium in the organs of the dog, using rubidium. Circ Res. 1954;2(2):112–22.PubMedCrossRef
68.
Chatal JF, Rouzet F, Haddad F, Bourdeau C, Mathieu C, Le Guludec D. Story of rubidium-82 and advantages for myocardial perfusion PET imaging. Front Med. 2015;2:65.CrossRef
69.
Curillova Z, Yaman BF, Dorbala S, Kwong RY, Sitek A, El Fakhri G, et al. Quantitative relationship between coronary calcium content and coronary flow reserve as assessed by integrated PET/CT imaging. Eur J Nucl Med Mol Imaging. 2009;36(10):1603–10.PubMedPubMedCentralCrossRef
70.
Assante R, Zampella E, Arumugam P, Acampa W, Imbriaco M, Tout D, et al. Quantitative relationship between coronary artery calcium and myocardial blood flow by hybrid rubidium-82 PET/CT imaging in patients with suspected coronary artery disease. J Nucl Cardiol. 2017;24(2):494–501.PubMedCrossRef
71.
von Scholten BJ, Hasbak P, Christensen TE, Ghotbi AA, Kjaer A, Rossing P, et al. Cardiac (82)Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes. Diabetologia. 2016;59(2):371–8.CrossRef
72.
Derlin T, Habermann CR, Lengyel Z, Busch JD, Wisotzki C, Mester J, et al. Feasibility of 11C-acetate PET/CT for imaging of fatty acid synthesis in the atherosclerotic vessel wall. J Nucl Med. 2011;52(12):1848–54.PubMedCrossRef
73.
Villa-Bellosta R, Hernández-Martínez E, Mérida-Herrero E, González-Parra E. Impact of acetate- or citrate-acidified bicarbonate dialysate on ex vivo aorta wall calcification. Sci Rep. 2019;9(1):11374.PubMedPubMedCentralCrossRef
74.
Gennari FJ, Sargent JA. Acetate metabolism, organic acid production, and the independent effects of bicarbonate and acetate as alkalinizing agents in dialysis bath solutions. Semin Dial. 2019;32(3):274–5.PubMedCrossRef
75.
Mason DL, Godugu K, Nnani D, Mousa SA. Effects of sevelamer carbonate versus calcium acetate on vascular calcification, inflammation, and endothelial dysfunction in chronic kidney disease. Clin Transl Sci. 2022;15(2):353–60.PubMedCrossRef
76.
Paravastu SS, Theng EH, Morris MA, Grayson P, Collins MT, Maass-Moreno R, et al. Artificial intelligence in vascular-PET: translational and clinical applications. PET Clin. 2022;17(1):95–113.PubMedCrossRef
77.
78.
Varga-Szemes A, Penmetsa M, Emrich T, Todoran TM, Suranyi P, Fuller SR, et al. Diagnostic accuracy of non-contrast quiescent-interval slice-selective (QISS) MRA combined with MRI-based vascular calcification visualization for the assessment of arterial stenosis in patients with lower extremity peripheral artery disease. Eur Radiol. 2021;31(5):2778–87.PubMedCrossRef
79.
80.
Adams LC, Böker SM, Bender YY, Fallenberg EM, Wagner M, Liebig T, et al. Detection of vessel wall calcifications in vertebral arteries using susceptibility weighted imaging. Neuroradiology. 2017;59(9):861–72.PubMedCrossRef
81.
Piri R, Edenbrandt L, Larsson M, Enqvist O, Nøddeskou-Fink AH, Gerke O, et al. Aortic wall segmentation in (18)F-sodium fluoride PET/CT scans: head-to-head comparison of artificial intelligence-based versus manual segmentation. J Nucl Cardiol. 2021. 
Metadata
Title
Advances in positron emission tomography tracers related to vascular calcification
Authors
Wenjun Yang
Zhiqi Zhong
Guoquan Feng
Zhongqun Wang
Publication date
14-07-2022
Publisher
Springer Nature Singapore
Published in
Annals of Nuclear Medicine / Issue 9/2022
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-022-01771-3

Other articles of this Issue 9/2022

Annals of Nuclear Medicine 9/2022 Go to the issue

Original Article

Crossed cerebellar diaschisis-related supratentorial hemodynamic and metabolic status measured by PET/MR in assessing postoperative prognosis in chronic ischemic cerebrovascular disease patients with bypass surgery

Letter to the Editor

Response to the letter to the editor

Original Article

Unusual perfusion patterns on perfusion-only SPECT/CT scans in COVID-19 patients

Letter to the Editor

The safe handling of 211At compounds

Review Article

Recent topics of the clinical utility of PET/MRI in oncology and neuroscience

Original Article

Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients